This short article aims to briefly introduce a methodology to address the challenge of rare clinical trials relying on Bayesian statistical methods, and the use of natural history data to determine the control group and inform the analytical model. You can read the full article here
Proposal for a Single Arm Clinical Study in Rare Disease using Bayesian Statistics
The contents of this article/presentation are solely the opinion of the author and do not represent the opinions of PharmaLex GmbH or its parent AmerisourceBergen Corporation. PharmaLex and AmerisourceBergen strongly encourage readers/listeners to review available information related to the topics mentioned herein and to rely on their own experience and expertise in making decisions related thereto.